Anjan Chatterji

Advisor at Oxeia Biopharma

Mr. Anjan Chatterji has over 10 years’ experience in the life sciences and biotech industries in several capacities and is the founding manager at Horatio Washington Ventures LLC (“HWV”). At HWV, Mr. Chatterji runs a mid-sized private and public equity long-short fund, focused mainly on pre-revenue healthcare businesses.

Mr. Chatterji has also published several white and peer-reviewed papers, one of which was cited in the final decree for reverse settlements in the Supreme Court’s decision in FTC v. Actavis et. al. Anjan earned his MBA and JD, as well as an LLM from Northwestern University. Mr. Anjan Chatterji’s professional, commercial and academic experiences have allowed him to understand where to find areas of stable growth in the healthcare and technology fields, and to truly relate to the needs of the companies his fund supports.